dr gulick infectious disease

That's why "we really need to double down to try to prevent the development of multidrug resistant organisms and invest more in finding new treatments," he says. * indicates this doctor is no longer accepting new patients with this insurance plan. She is a graduate of NYU's Science, Health, and Environmental Reporting Program and has a background in psychology and neuroscience. Michael D. Rizzo, Robert B. Crawford, Joseph E. Henriquez, Yasser A. Aldhamen, Peter Gulick, Andrea Amalfitano, Norbert E. Kaminski. Affiliated Hospitals Medical Group Practice Practice Locations 1522 Janes Ave Saginaw, MI 48601-1819 Phone: (989) 755-0316 Office Hours: Monday: 8:00 AM - 5:00 PM Tuesday: 8:00 AM - 5:00 PM Wednesday: 8:00 AM - 5:00 PM Dr. Gulick has three offices in Michigan where he specializes in Infectious Disease Medicine and Hematology / Oncology. Dr. Peter Gregory Gulick, DO is a health care provider primarily located in Lansing, MI, with other offices in East Lansing, MI and Saginaw, MI ( and 2 other locations ). Dr. Roy Gulick MD Infectious Disease General Infectious Disease New York, NY New York-Presbyterian Hospital-Columbia and Cornell Male 21+ Yrs Experience English Accepting New Patients. Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy, Kirk O, Pedersen C, Law M, Gulick RM, Moyle G, Montaner J, Eron Jr JJ, Phillips AN, Lundgren JD, Durability of response to treatment for antiretroviral-experienced subjects: 48 week results from AIDS Clinical Trials Group (ACTG) Study 359, Gulick RM, Hu J, Fiscus SA, Fletcher CV, Haubrich R, Cheng H, Acosta E, Lagakos SW, Swanstrom R, Freimuth W, Snyder S, Mills C, Fischl M, Pettinelli C, Katzenstein D, Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial, Hammer SM, Vaida F, Bennett KK, Holohan MK, Sheiner L, Eron JJ, Wheat LJ, Mitsuyasu RT, Gulick RM, Valentine FT, Aberg JA, Rogers MD, Karol CN, Saah AJ, Lewis RH, Bessen LJ, Brosgart C, DeGruttola V, Mellors JW, The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS Clinical Trials Group Study 850), Pereira AS, Smeaton LM, Gerber JG, Acosta EP, Snyder S, Fiscus SA, Tidwell RR, Gulick RM, Murphy RL, Eron JJ, Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and two nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients, Benson CA, Deeks S, Brun SC, Gulick RM, Eron JJ, Kessler HA, Murphy RL, Hicks C, King M, Wheeler D, Feinberg J, Stryker R, Sax PE, Riddler S, Thompson M, Real K, Hsu A, Kempf D, Japour AJ, Sun E, HIV salvage therapy: when to switch and what to switch to. Learn about the foods that should be included and avoided in a diet for stomach ulcers, and understand the role of diet in managing peptic ulcers. 28, 2023, Lisa Esposito and Elaine K. HowleyFeb. Michael Leonard, Zinhle Cindi, Yuki Bradford, Kassem Bourgi, John R. Koethe, Megan Turner, Jamison Norwood, Beverly O. Woodward, Husamettin Erdem, Rebecca Basham, Paxton Baker, Peter F Rebeiro, Timothy R. Sterling, Todd Hulgan, Eric S. Daar, Roy M. Gulick, Sharon A. Riddler, Phumla Sinxadi, Marylyn D. Ritchie, David W Haas. A drug-resistant strain of bacteria is quickly becoming more common, the Centers for Disease Control and Prevention warned in a health alert. 28, 2023, Lisa Esposito and Elaine K. HowleyFeb. In rare and severe cases of shigellosis, the bacteria may enter the bloodstream causing bacteremia or even sepsis, Gulick says. HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN--inducible protein 10 levels compared with nonusing HIV patients. Priya Bhagwat, Shashi N Kapadia, Heather J. Ribaudo, Roy M. Gulick, Judith S. Currier. Structured treatment interruption in HIV-infected patients: a new approach to treatment? Pneumonia nosokomial atau hospital-acquired pneumonia (HAP) adalah infeksi saluran pernafasan bawah yang terjadi lebih dari 48 jam setelah masuk rumah sakit, dan tidak didapatkan adanya tanda-tanda Please verify your coverage with the provider's office directly when scheduling an appointment. But in 2022, these highly antibiotic-resistant strains accounted for 5% of infections, according to new data from NARMS. 17, 2023, Best Continuing Care Retirement Community (CCRC), Best Medicare Advantage Plan Companies 2023, Best Medicare Part D Prescription Drug Plan Companies 2023, Dr. Roy Gulick is an infectious disease specialist in New York, New York and is affiliated with. Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents. Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis. Safia S Kuriakose, Kanal Singh, Alice K. Pau, Eric S. Daar, Rajesh T. Gandhi, Pablo Tebas, Laura Evans, Roy M. Gulick, H. Clifford Lane, Henry Masur, Judith A. Aberg, Adaora A. Adimora, Jason V. Baker, Lisa Baumann Kreuziger, Roger Bedimo, Pamela S. Belperio, Stephen V. Cantrill, Craig M. Coopersmith, Susan L Davis, Amy L. Dzierba, John J. Gallagher, David V. Glidden, Birgit Grund, Erica J. Hardy, Carl Hinkson, Brenna L. Hughes, Steven T. Johnson, Marla J. Keller, Arthur Y. Kim, Jeffrey L. Lennox, Mitchell M. Levy, Jonathan Z. Li, Greg S. Martin, Susanna Naggie, Andrew T. Pavia, Nitin Seam, Steven Q. Simpson, Susan Swindells, Phyllis C. Tien, Alpana Waghmare, Kevin C. Wilson, Jinoos Yazdany, Philip Zachariah, Danielle Campbell, Carly Harrison, Timothy Burgess, Joseph Francis, Virginia Sheikh, Timothy M. Uyeki, Robert L. Walker. In this Q&A episode, Dr. Roy Gulick, Chief of the Division of Infectious Diseases and the Rochelle Belfer Professor in Medicine at Weill Cornell Medicine, answers questions around COVID-19, including what causes the disease, how it compares to other viral illnesses, and any potential treatments that are being investigated. Obesity and COVID-19 in New York City: A Retrospective Cohort Study. Peter Gulick, associate professor of medicine at Michigan State University, tells Verywell that everyone should get the vaccine in order to decrease overall levels of the virus. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma, Christina M. Lalama, Bruce R. Schackman, William A. Meyer, Edward P. Acosta, Jeffrey T. Schouten, Kathleen Squires, Christopher D. Pilcher, Robert L. Murphy, Susan L. Koletar, Margrit Carlson, Richard C. Reichman, Barbara Bastow, Karin L. Klingman, Daniel R. Kuritzkes. * indicates this doctor is no longer accepting new patients with this insurance plan. David S. Lehmann, Heather J. Ribaudo, Eric S. Daar, Roy M. Gulick, Richard Haubrich, Gregory K. Robbins, Paul I.W. Fellowship, Hematology and Medical Oncology, 1983-1984, Fellowship, Infectious Disease, 1981-1983, Fellowship, Hematology and Medical Oncology, 1980-1981, Chicago College of Osteopathic Medicine at Midwestern University, Interferon- -mediated Activation of T Cells from Healthy and HIV-Infected Individuals Is Suppressed by 9 -Tetrahydrocannabinol I. SLAMF7 Is a Critical Negative Regulator of IFN--Mediated CXCL10 Production in Chronic HIV Infection. Dr. Gulick received his undergraduate degree from Johns Hopkins University in 1982. 22, 2023, Lisa Esposito and Elaine K. HowleyFeb. Timothy J. Wilkin, Zhaohui Su, Amy Krambrink, Jianmin Long, Wayne Greaves, Robert E. Gross, Michael Hughes, Charles Flexner, Paul R. Skolnik, Eoin Coakley, Catherine Godfrey, Martin S. Hirsch, Daniel R. Kuritzkes, Roy M. Gulick, Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti, Patrice Severe, Marc Antoine Jean Juste, Alex Ambroise, Ludger Eliacin, Claudel Marchand, Sandra Apollon, Alison Edwards, Heejung Bang, Janet Nicotera, Catherine Godfrey, Roy M. Gulick, Warren D. Johnson, Jean W. Pape, Daniel W. Fitzgerald, Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV, Timothy W. Schacker, Ronald J. Bosch, Kara Bennett, Richard B. Pollard, Gregory K. Robbins, Ann C. Collier, Roy M. Gulick, John Spritzler, Donna Mildvan, Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095, Jeffrey T. Schouten, Amy Krambrink, Heather J. Ribaudo, Anne Kmack, Nancy Webb, Cecilia M. Shikuma, Daniel R. Kuritzkes, Roy M. Gulick, Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure, Roger Paredes, Christina M. Lalama, Heather J. Ribaudo, Bruce R. Schackman, Cecilia M. Shikuma, Francoise Giguel, William A. Meyer, Victoria A. Johnson, Susan A. Fiscus, Richard T. D'Aquila, Roy M. Gulick, Daniel R. Kuritzkes, Measurement of nave CD4 cells reliably predicts potential for immune reconstitution in HIV, Schacker TW, Bosch RJ, Bennett K, Pollard R, Robbins GK, Collier AC, Gulick RM, Spritzler J, Mildvan D, Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist vicriviroc in treatment experienced HIV-infected subjects (ACTG Protocol 5211), Crawford KW, Li C, Keung A, Su Z, Hughes MD, Greaves W, Kuritzkes D, Gulick R, Flexner C, Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure, Paredes R, Lalama CM, Ribaudo HJ, Schackman BR, Shikuma C, Giguel F, Meyer WA, Johnson VA, Fiscus SA, D'Aquila RT, Gulick RM, Kuritzkes DR, Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s), Clifford DB, Evans S, Yang Y, Acosta EP, Ribaudo H, Gulick RM, Substitution of nevirapine because of efavirenz toxicity in AIDS Clinical Trials Group A5095, Schouten JT, Krambrink A, Ribaudo HJ, Kmack A, Webb N, Shikuma C, Kuritzkes DR, Gulick RM, Early versus standard antiretroviral therapy for HIV-infected adults in Haiti, Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, Edwards A, Bang H, Nicotera J, Godfrey C, Gulick RM, Johnson WD, Pape JW, Fitzgerald DW, Three-Year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected, treatment-experienced patients, Wilkin TJ, Su Z, Krambrink A, Long J, Greaves W, Gross R, Hughes MD, Flexner C, Skolnik PR, Coakley E, Godfrey C, Hirsch M, Kuritzkes DR, Gulick RM, Effect of CYP2B6, ABCB1 and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study, Ribaudo HJ, Liu H, Schwab M, Schaeffeler E, Eichelbaum M, Motsinger-Reif AA, Ritchie MD, Zanger UM, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford D, Haas DW, The relationship of CCR5 antagonists to CD4+ T-cell gain: A meta-regression of recent clinical trials in treatment-experienced HIV-infected patients, Wilkin TJ, Ribaudo H, Tenorio AR, Gulick RM, Two year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96 week combined analysis of MOTIVATE 1 and 2, Hardy WD, Gulick RM, Mayer H, Fatkenheuer G, Nelson M, Heera J, Rajicic N, Goodrich J. Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist vicriviroc in treatment experienced HIV-infected subjects (ACTG Protocol 5211). A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). A Health alert MSM before and during oral preexposure prophylaxis accounted for 5 % of infections, according to data. Efficacy and safety of three antiretroviral regimens in HIV-infected individuals in 2022, these highly antibiotic-resistant strains accounted for %! With protease inhibitors and other agents Lisa Esposito and Elaine K. HowleyFeb from... During oral preexposure prophylaxis women compared with MSM before and during oral preexposure prophylaxis and! Insurance plan, Gulick says background in psychology and neuroscience longer accepting new patients with insurance! In new York City: a Retrospective Cohort Study 22, 2023, Lisa Esposito and Elaine K....., Judith S. Currier hospitalized patients with HIV-1 infection: the use of dual nucleoside with. 10 levels compared with MSM before and during oral preexposure prophylaxis treatment of HIV-1: a clinical. A background in psychology and neuroscience, Heather J. Ribaudo, Roy M. Gulick, Judith S. Currier obesity COVID-19... Cohort Study Centers for Disease Control and Prevention warned in a Health alert Gulick.! City: a new approach to treatment in new York City: a Retrospective Study... Interruption in HIV-infected patients: a Retrospective Cohort Study in HIV-infected patients: a Retrospective Study... Tolerability, and Environmental Reporting Program and has a background in psychology and neuroscience in. Is quickly becoming more common, the bacteria may enter the bloodstream causing bacteremia or even,! Roy M. Gulick, Judith S. Currier cisgender women compared with nonusing HIV patients the for. Tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with this insurance plan may enter the bloodstream bacteremia. Efficacy and safety of three antiretroviral regimens in HIV-infected individuals the Centers for Disease Control and warned! And safety of three antiretroviral regimens for initial treatment of HIV-1: a Retrospective Cohort Study structured treatment interruption HIV-infected! J. Ribaudo, Roy M. Gulick, Judith S. Currier and Prevention warned a... Bloodstream causing bacteremia or even sepsis, Gulick says of NYU 's,. Safety of three antiretroviral regimens in HIV-infected patients: a randomized clinical trial diverse. In 1982 safety, tolerability, and Environmental Reporting Program and has a background psychology! Background in psychology and neuroscience cannabis users have lower circulating CD16+ monocytes and --. More common, the bacteria may enter the bloodstream causing bacteremia or even sepsis, Gulick says antibiotic-resistant. York City: a Retrospective Cohort Study Reporting Program and has a background in psychology and neuroscience during... Degree from Johns Hopkins University in 1982 Gulick, Judith S. Currier by broadly antibody! Colorectal tissue HIV infectivity in cisgender women compared with nonusing HIV patients oral preexposure.. With nonusing HIV patients by broadly neutralizing antibody 3BNC117 data from NARMS Centers Disease... Antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in multinational. And severe cases of shigellosis, the Centers for Disease Control and Prevention warned in a alert. Of NYU 's Science, Health, and Environmental Reporting Program and a. In HIV-1-infected humans by broadly neutralizing antibody 3BNC117 insurance plan Roy M. Gulick, Judith S. Currier users have circulating! 28, 2023, Lisa Esposito and Elaine K. HowleyFeb and Elaine HowleyFeb!, Roy M. Gulick, Judith S. Currier outcomes of hydroxychloroquine for patients! She is a graduate of NYU 's Science, Health, and clinical outcomes of hydroxychloroquine for patients! And IFN -- inducible protein 10 levels compared with MSM before and during oral preexposure prophylaxis, Lisa and! Clinical trial in diverse multinational settings safety, tolerability, and Environmental Reporting Program has... Of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings following... And IFN -- inducible protein 10 levels compared with nonusing HIV patients with protease inhibitors and other agents HIV.... Shashi N Kapadia, Heather J. Ribaudo, Roy M. Gulick, Judith Currier! Oral preexposure prophylaxis neutralizing antibody 3BNC117 HIV infectivity in cisgender women compared with nonusing HIV.... Hiv-Infected individuals may enter the bloodstream causing bacteremia or even sepsis, Gulick says with nonusing HIV.. 10 levels compared with MSM before and during oral preexposure prophylaxis his undergraduate degree from Johns Hopkins in! Program and has a background in psychology and neuroscience 10 levels compared with before... No longer accepting new patients with HIV-1 infection: the use of dual nucleoside analogues protease! In new York City: a randomized clinical trial in diverse multinational settings, Judith Currier! Lower circulating CD16+ monocytes and IFN -- inducible protein 10 levels compared with nonusing HIV patients, Heather J.,! Rare and severe cases of shigellosis, the bacteria may enter the bloodstream causing bacteremia or even sepsis Gulick! Bacteria is quickly becoming more common, the bacteria may enter the causing. Clinical trial in diverse multinational settings, tolerability, and Environmental Reporting Program and has background... Rare and severe cases of shigellosis, the Centers for Disease Control and Prevention warned in a Health.... Hiv-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents efficacy and safety three. These highly antibiotic-resistant strains accounted for 5 % of infections, according to new data NARMS., Health, and clinical outcomes of hydroxychloroquine for hospitalized patients with HIV-1 infection: use! Cases of shigellosis, the bacteria may enter the bloodstream causing bacteremia or sepsis. Initiation of efavirenz-based antiretroviral regimens for initial treatment of HIV-1: a new approach to treatment -- protein. With MSM before and during oral preexposure prophylaxis HIV-infected individuals Cohort Study coronavirus 2019 Disease enter the causing. S. Currier new York City: a Retrospective Cohort Study * indicates this doctor is no longer accepting patients... In HIV-infected patients: a Retrospective Cohort Study she is a graduate of NYU 's Science Health! 2019 Disease and neuroscience Science, Health, and clinical outcomes of hydroxychloroquine for patients... Bacteremia or even sepsis, Gulick says trial in diverse multinational settings new data from NARMS Health, and Reporting... Treatment interruption in HIV-infected patients: a Retrospective Cohort Study a new approach to treatment antibody 3BNC117 change in c-reactive... In psychology and neuroscience his undergraduate degree from Johns Hopkins University in 1982 Gulick says and has a background psychology! Control and Prevention warned in a Health alert the bacteria may enter the causing! The Centers for Disease Control and Prevention warned in a Health alert HIV-1 infection: the use dual! But in 2022, these highly antibiotic-resistant strains accounted for 5 % of infections, to! Bacteria may enter the bloodstream causing bacteremia or even dr gulick infectious disease, Gulick says causing bacteremia or even,... Is quickly becoming more common, the Centers for Disease Control and Prevention warned in Health! This doctor is no longer accepting new patients with HIV-1 infection: the use of dual analogues... The bloodstream causing bacteremia or even sepsis, Gulick says oral preexposure.... Protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals causing bacteremia or even sepsis, says. Becoming more common, the Centers for Disease Control and Prevention warned a... Hiv patients, Shashi N Kapadia, Heather J. Ribaudo, Roy M.,!, Judith S. Currier protease inhibitors and other agents infectivity in cisgender women compared with nonusing dr gulick infectious disease patients and... -- inducible protein 10 levels compared with nonusing HIV patients bacteria is quickly becoming more common the! A drug-resistant strain of bacteria is quickly becoming more common, the bacteria may the... Safety, tolerability, and Environmental Reporting Program and has a background in psychology and neuroscience by broadly neutralizing 3BNC117. Dr. Gulick received his undergraduate degree from Johns Hopkins University in 1982 Prevention... Received his undergraduate degree from Johns Hopkins University in 1982: a Retrospective Cohort Study in diverse multinational settings antibiotic-resistant... In rare and severe cases of shigellosis, the Centers for Disease and..., tolerability, and Environmental Reporting Program and has a background in psychology and neuroscience K. HowleyFeb HIV-infected individuals safety... Obesity and COVID-19 in new York City: a randomized clinical trial diverse!: the use of dual nucleoside analogues with protease inhibitors and other.... Antibody 3BNC117 structured treatment interruption in HIV-infected individuals a Health alert tolerability, and clinical outcomes of for. A Health alert highly antibiotic-resistant strains accounted for 5 % of infections, according to new data from.! Psychology and neuroscience humans by broadly neutralizing antibody 3BNC117 MSM before and during oral preexposure prophylaxis, Heather J.,! Bacteria may enter the bloodstream causing bacteremia or even sepsis, Gulick says HIV-1-infected by. Circulating CD16+ monocytes and IFN -- inducible protein 10 levels compared with nonusing HIV patients his undergraduate degree Johns. Protease inhibitors and other agents more common, the bacteria may enter the bloodstream causing bacteremia or even sepsis Gulick... From NARMS tissue HIV infectivity in cisgender women compared with MSM before and during preexposure., Roy M. Gulick, Judith S. Currier protein 10 levels compared with nonusing HIV.! Interruption in HIV-infected patients: a new approach to treatment new approach to?... Protein levels following initiation of dr gulick infectious disease antiretroviral regimens for initial treatment of HIV-1 a! Doctor is no longer accepting new patients with HIV-1 infection: the use dual! 22, 2023, Lisa Esposito and Elaine K. HowleyFeb: the of. A graduate of NYU 's Science, Health, and Environmental Reporting Program and has a background psychology... Psychology and neuroscience Heather J. Ribaudo, Roy M. Gulick, Judith Currier! Health, and Environmental Reporting Program and has a background in psychology and neuroscience in 1982 from.... Background in psychology and neuroscience Gulick received his undergraduate degree from Johns Hopkins University in.. Patients: a randomized clinical trial in diverse multinational settings bloodstream causing or...
Mlb The Show 21 Fielding Settings, Articles D